Serge inspire

Nipro Medical Europe, a global market leader in renal care, is strengthening its position with the successful acquisition of German ‘MTN Neubrandenburg’. This acquisition fits Nipro’s renal care strategy of being a solid total solution provider for its customers.

Although regulatory approvals are still pending, the activities of MTN are expected to be integrated into Nipro within the next three months.

Enhancing Nipro’s position as a Total Renal Care Solution Provider

Nipro is investing further in the manufacture of acid concentrates for hemodialysis. This acquisition is an important strategic addition to Nipro’s development as it adds significantly to its capacity in ‘concentrates’ and it also enlarges Nipro’s product portfolio.

Through the acquisition, Nipro is now able to optimize its supply chain by balancing between its 2 manufacturing units: MTN in Germany and Nipro Renal Solutions in Spain. Moreover, the location of MTN allows Nipro to expand its geographical market reach.

Introducing MTN

Situated in Germany, the company draws upon 3 decades of expertise in the manufacture of dialysis concentrates and employs about 70 colleagues.
Holding dear to their value of ‘reliability’ both in premium quality and flexibility, MTN has built a solid reputation in the market and enjoys many long-lasting customer relationships.

Integrating MTN as part of our commitment towards the patient

We welcome the MTN family into our group and look forward to building a great future together with them. Both companies share the same vision to always have the patient in mind. We take pride in Nipro’s responsibility to society as we develop our business in innovative, value-added products and technologies that improve patient outcomes and healthcare worldwide.
Serge Kemps - CEO Nipro Medical Europe
Serge Kemps
Questions ?  Additional information needed ?

Thank you for your continued interest.  For further information,  we invite you to write an E-mail to